Vaccines to Prevent Dengue Fever Advanced Tech
Abstract
This Project covers technology development, demonstration, and transition of a candidate vaccine for the prevention of dengue hemorrhagic fever or dengue shock syndrome caused by any of the 4 dengue virus types. The vaccine will be effective in people with and without a prior history of dengue infection. Infectious disease prevention sustains individual and unit readiness and reduces health services requirements and cost. Work in this Project is managed by the United States (U.S.) Army Medical Research and Materiel Command (USAMRMC) in coordination with the Naval Medical Research Center (NMRC). The Army is responsible for programming and funding all Department of Defense (DoD) naturally occurring infectious disease research requirements, thereby precluding duplication of effort within the Military Departments. Promising medical countermeasures identified in this Project are further matured under PE 0603807A, Project 808. The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. All FY 2020 adjustments align program resources to Army Modernization Priorities in support of the National Defense Strategy. Work in this Project is performed by USAMRMC at Fort Detrick, MD. Efforts in this Project support the Soldier portfolio and the principal area of Military Relevant Infectious Diseases.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2020
- Source ID
- MO9_0603002A_3_2040_PB_2020
Related Documents
- Root: Medical Advanced Technology
- Child Accomplishment: Vaccines to Prevent Dengue Fever Advanced Technology